ShareValue scores for AT1.AU: Valuation 53, Quality 48, Growth 50, Health 46.
AT1.AUASX
Atomo Diagnostics Ltd
A$0.02
(0.00%)
AT1.AUASX
Atomo Diagnostics Ltd
A$0.02(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 17%
Rating
Trap Risk
Return
6% to 17%
Valuation
53
Fair Value
Price vs Value
Quality
48
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
46
Moderate
Financial Stability
Momentum
29
Bearish
Price Trend
Company Details
About
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Market Cap$15M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1485
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026